We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Endogenous Progenitors Cell Therapy for Diabetic Foot Ulcers (AMD3100)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01353937
Recruitment Status : Withdrawn (Never Activated)
First Posted : May 16, 2011
Last Update Posted : March 4, 2016
National Institutes of Health (NIH)
Genzyme, a Sanofi Company
Information provided by (Responsible Party):
New York University School of Medicine

No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Recruitment Status : Withdrawn
  Estimated Primary Completion Date : March 2016
  Estimated Study Completion Date : September 2016